14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $224.91 $224.91 Friday, 27th May 2022 MYOK stock ended at $224.91. During the day the stock fluctuated 0% from a day low at $224.91 to a day high of $224.91.
90 days $224.91 $224.91
52 weeks $224.91 $224.91

Historical MyoKardia prices

Date Open High Low Close Volume
May 27, 2022 $224.91 $224.91 $224.91 $224.91 0
May 26, 2022 $224.91 $224.91 $224.91 $224.91 0
May 25, 2022 $224.91 $224.91 $224.91 $224.91 0
May 24, 2022 $224.91 $224.91 $224.91 $224.91 0
May 23, 2022 $224.91 $224.91 $224.91 $224.91 0
May 20, 2022 $224.91 $224.91 $224.91 $224.91 0
May 19, 2022 $224.91 $224.91 $224.91 $224.91 0
May 18, 2022 $224.91 $224.91 $224.91 $224.91 0
May 17, 2022 $224.91 $224.91 $224.91 $224.91 0
May 16, 2022 $224.91 $224.91 $224.91 $224.91 0
May 13, 2022 $224.91 $224.91 $224.91 $224.91 0
May 12, 2022 $224.91 $224.91 $224.91 $224.91 0
May 11, 2022 $224.91 $224.91 $224.91 $224.91 0
May 10, 2022 $224.91 $224.91 $224.91 $224.91 0
May 09, 2022 $224.91 $224.91 $224.91 $224.91 0
May 06, 2022 $224.91 $224.91 $224.91 $224.91 0
May 05, 2022 $224.91 $224.91 $224.91 $224.91 0
May 04, 2022 $224.91 $224.91 $224.91 $224.91 0
May 03, 2022 $224.91 $224.91 $224.91 $224.91 0
May 02, 2022 $224.91 $224.91 $224.91 $224.91 0
Apr 29, 2022 $224.91 $224.91 $224.91 $224.91 0
Apr 28, 2022 $224.91 $224.91 $224.91 $224.91 0
Apr 27, 2022 $224.91 $224.91 $224.91 $224.91 0
Apr 26, 2022 $224.91 $224.91 $224.91 $224.91 0
Apr 25, 2022 $224.91 $224.91 $224.91 $224.91 0
Click to get the best stock tips daily for free!

About MyoKardia

MyoKardia MyoKardia, Inc., a clinical stage biopharmaceutical company, engages in discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). The company also develops DCM-1, a drug compound ... MYOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT